Sub-specialty:

• Medical Oncology
  
  

Medical Conditions Treated:

• Pancreatic cancer
• Liver cancer
• Gallbladder cancer
• Cholangiocarcinoma (cancer of the bile ducts)
  
  

Languages:

English, Mandarin, Hokkien

Education:

MBBS, MRCP(UK), FAMS

Professional Profile:

Dr Choo Su Pin’s medical specialisation is in gastrointestinal cancers, especially pancreatico-hepatobiliary cancers. She was previously Deputy Head and Chief of the Gastrointestinal Cancer Service in the Division of Medical Oncology at the National Cancer Centre Singapore (NCCS), where she was involved in various important roles, including the founding director of the Experimental Cancer Treatment Unit and codirector of the Comprehensive Liver Cancer Clinic.

Dr Choo is known for her research on gastrointestinal cancers, including her involvement in the development of the first immunotherapy drug approved for use in liver cancer. She received her Medical Degree from the University of Nottingham in the United Kingdom and has fellowships from the Royal College of Physicians, UK and the Academy of Medicine, Singapore. She also completed a one-year fellowship at UCSF Comprehensive Cancer Center.

Currently, Dr Choo remains involved in research on pancreatico-hepatobiliary cancers as a visiting consultant at NCCS. She also holds the positions of Adjunct Associate Professor at the Singhealth Duke-NUS Oncology Academic Clinic Programme, Duke-NUS Graduate Medical School Singapore, and Adjunct Associate Professor at the Department of Medicine, Yong Loo Lin Medical School, National University of Singapore, where she is involved in research mentorship and clinical teaching. Dr Choo has also served on advisory boards of pharmaceutical companies for gastrointestinal cancer drug development and delivered talks on gastrointestinal cancers at both national and international conferences. She serves as an invited reviewer of the NCCN hepatobiliary cancer guidelines.